Sign in

CIK 0001347178 · Accelerated filer

Vanda Pharmaceuticals Inc.

Sign in to watch
Ticker
VNDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
030491827
Phone
202-734-3400
Business address
2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
Open-market buys, last 90 days
$38,094
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$38,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Duncan Charles Cliff +$38K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-06-16 DUGAN RICHARD W Director Grant or award · Stock Option (Right to Buy) +24,707 24,707
2022-06-16 Chrousos Phaedra Director Grant or award +12,006 24,931
2022-06-16 Chrousos Phaedra Director Grant or award · Stock Option (Right to Buy) +24,707 24,707
2022-06-13 Mitchell Stephen Ray Director Sale −2,700 $9.48 $26K 6,515
2022-06-02 Watkins Thomas Director Option exercise +15,000 $4.15 $62K 69,505
2022-06-02 Watkins Thomas Director Sale −6,441 $9.90 $64K 63,064
2022-06-02 Watkins Thomas Director Option exercise · Stock Option (Right to Buy) −15,000 0
2022-05-31 DUGAN RICHARD W Director Option exercise +15,000 $4.15 $62K 74,887
2022-05-31 DUGAN RICHARD W Director Sale −6,500 $9.85 $64K 68,387
2022-05-31 DUGAN RICHARD W Director Option exercise · Stock Option (Right to Buy) −15,000 0
2022-03-02 Williams Timothy SVP & General Counsel Sale −12,060 $11.09 $134K 103,851
2022-02-28 Williams Timothy SVP & General Counsel Grant or award +32,700 115,911
2022-02-28 Williams Timothy SVP & General Counsel Grant or award · Stock Option (Right to Buy) +77,500 77,500

Page 8 of 8 · 153 trades